Abstract

Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines

Author(s): Pruitt Bobby N III

Issue: Sep/Oct 2013 - Volume 17, Number 5

Page(s): 384-387

Download in electronic PDF format for $75
  • Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines Page 1
  • Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines Page 2
  • Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines Page 3
  • Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines Page 4

Abstract

Rhabdomyolysis in equines occurs in horses due to physical overexertion or underlying pathologic myopathy. Methocarbamol is a muscle relaxant that can be used in equines to treat symptoms associated with rhabdomyolysis. Methocarbamol is available as a solution for injection but is not commercially available as an oral suspension. This article focuses on the treatment of tying-up caused by overexertion, and details the treatment of rhabdomyolysis with an oral suspension that was prepared for a veterinarian by a compounding pharmacist.

Related Keywords

  • methocarbamol
  • formulation
  • horses
  • rhabdomyolysis
  • overexertion
  • myopathy
  • tying up syndrome
  • muscle disorders
  • muscle relaxant
  • case report
  • oral suspension
  • flavoring
  • flavors
  • excipients

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • VETERINARY
  • CASE REPORTS
  • DOSAGE FORMS/DRUG CARRIERS
  • MUSCULOSKELETAL DISORDERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2013
Pg. 384-387
Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines
Author(s): Pruitt Bobby N III
Jan/Feb 2003
Pg. 48-50
Featured Excipient: Flavor Enhancing Agents
Author(s): Allen Loyd V Jr
Mar/Apr 1997
Pg. 90-92
Flavors and Flavoring
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Jan/Feb 2003
Pg. 27-29
Equine Cushing’s Syndrome
Author(s): Vail Jane
Sep/Oct 2012
Pg. 424
Methocarbamol 100-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jul/Aug 1997
Pg. 242-243
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease
Author(s): Patterson Donna, Ford Peter R, Gallon Marlene D
Jan/Feb 2001
Pg. 13-16
Flavoring: Compounding a Treat
Author(s): Kloesel Lawson G
Nov/Dec 2017
Pg. 500-512
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Author(s): Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
Nov/Dec 2019
Pg. 487
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
Sep/Oct 2013
Pg. 388-391
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1
Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Jan/Feb 2009
Pg. 6-12
Compounding for Pediatric Patients: Case Reports and Formulations
Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Jan/Feb 2010
Pg. 40-45
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jul/Aug 2003
Pg. 302
Methocarbamol 400-mg and Aspirin 325-mg Capsules
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 270-276
Case Report in Equine: Highlighting the Benefits of Medisca CopaSil in Burn Scar Management
Author(s): Heuerman Jason, Haiub Halema, Cull Erica, Lupatini Rodrigo, Shrum Brandon, Sidhu Raman
Jul/Aug 2018
Pg. 270-278
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Nov/Dec 2019
Pg. 504-510
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Author(s): Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G